Skip to Content

Y70 (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint Y70 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Aurobindo Pharma Limited.

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Y70

Rabeprazole Sodium Delayed-Release

Imprint
Y70
Strength
20 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
National Drug Code (NDC)
65862-0721
Inactive Ingredients
diacetylated monoglycerides, ethylcellulose (7 mPa.s), ferric oxide yellow, hypromellose phthalate (31% phthalate, 40 cst), magnesium stearate, mannitol, magnesium oxide, magnesium hydroxide, sodium carbonate, magnesium silicate, titanium dioxide, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "Y70"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.